tranylcypromine
Brand names: Parnate
Tranylcypromine (Parnate) is a medicine used to treat major depression in adults. It is used when other antidepressants have not worked well enough.
Drug Shortage Alert
tranylcypromine is currently listed as to be discontinued by the FDA. Affected manufacturer: Teva Pharmaceuticals USA, Inc..
View all drug shortages →Drug Pricing (NADAC)
Generic Price
$0.70/unit
Generic Available
Yes (3 manufacturers)
Pricing data from NADAC (CMS), effective December 18, 2024. Compare all drug costs →
What it does
Tranylcypromine is used to treat major depressive disorder (MDD) in adults.
Common side effects
Dry mouth, Dizziness, Trouble sleeping
Key warnings
Tranylcypromine can increase the risk of suicidal thoughts and behaviors in young adults.
How It Works
Tranylcypromine belongs to a class of drugs called MAO inhibitors. It works by increasing the levels of certain chemicals in your brain. These chemicals can help improve your mood.
How to Take It
Take tranylcypromine by mouth. The usual starting dose is 30 mg per day, divided into smaller doses. If needed, your doctor may increase the dose by 10 mg every 1 to 3 weeks. The maximum dose is 60 mg per day, divided into two doses.
Pregnancy & Breastfeeding
There is limited information about the safety of tranylcypromine during pregnancy. Talk to your doctor if you are pregnant or plan to become pregnant. It is not recommended to breastfeed while taking this medicine because it can harm the baby.
Missed Dose
If you miss a dose, take it as soon as you remember. If it is almost time for your next dose, skip the missed dose and continue with your regular schedule.
Storage
Store tranylcypromine at room temperature, between 59° and 86°F (15° and 30°C), in a tightly closed, light-resistant container.
Side Effects (from patient reports)
Based on 302 FDA adverse event reports.
FDA Adverse Event Report Analysis
Detailed analysis of 329 reports from the FDA Adverse Event Reporting System (FAERS). Reports span 2004–2025.
Total Reports
329
Death-Related Reports
49
Hospitalization Reports
116
Top Indication
Product Used For Unknown Indication
Gender Distribution
Age Distribution
Most Reported Adverse Reactions (FAERS)
| # | Reaction | Reports |
|---|---|---|
| 1 | DRUG INTERACTION | 68 |
| 2 | DEPRESSION | 36 |
| 3 | DRUG INEFFECTIVE | 31 |
| 4 | SEROTONIN SYNDROME | 27 |
| 5 | HEADACHE | 24 |
| 6 | HYPERTENSION | 24 |
| 7 | SUICIDAL IDEATION | 24 |
| 8 | ATRIOVENTRICULAR SEPTAL DEFECT | 23 |
| 9 | HYPERTENSIVE CRISIS | 23 |
| 10 | CONTRAINDICATED PRODUCT ADMINISTERED | 22 |
| 11 | DYSMORPHISM | 22 |
| 12 | HYPERHIDROSIS | 22 |
| 13 | MUSCLE SPASMS | 21 |
| 14 | INSOMNIA | 20 |
| 15 | NAUSEA | 20 |
Reactions in Death Reports
Reactions in Hospitalization Reports
Source: FDA FAERS (Adverse Event Reporting System) FDA FAERS (Adverse Event Reporting System) Reports are voluntary and do not establish causation
Serious Warnings
Tranylcypromine can increase the risk of suicidal thoughts and behaviors in young adults. It can also cause a dangerous increase in blood pressure if you eat foods high in tyramine or take certain medicines. Make sure to follow all food and drug restrictions.
Known Drug Interactions
Excessive reduction of blood glucose (additive effect) [See Warnings and Precautions (5.14)] ; CNS depressant agents (including opioids, alcohol, sedatives, hypnotics) Use with caution Increased CNS depression Dietary supplements containing sympathomimetics Contraindicated Antidepressants including but not limited to: • Other MAOIs (e.g., linezolid, intravenous methylene blue, selective MAOIs) • Selective serotonin reuptake inhibitors (SSRIs) and serotonin and norepinephrine reuptake inhibitors (SNRIs) • Tricyclic antidepressants • Amoxapine, bupropion, maprotiline, nefazodone, trazodone, v...
Mechanism: These two antidepressants can cause a severe reaction when used at the same time. They both change brain chemicals in a way that can lead to dangerously high blood pressure.
What to do: Do not take these medications together. You must wait a specific amount of time when switching between these drugs to avoid serious side effects.
If in the absence of therapeutic alternatives and emergency treatment with a contraindicated drug (e.g., linezolid, intravenous methylene blue, direct-acting sympathomimetic drugs such as epinephrine) becomes necessary and cannot be delayed, discontinue tranylcypromine tablets as soon as possible before initiating treatment with the other agent, and monitor closely for adverse reactions. Excessive reduction of blood glucose (additive effect) [See Warnings and Precautions (5.14)] ; CNS depressant agents (including opioids, alcohol, sedatives, hypnotics) Use with caution Increased CNS depress...
Mechanism: Both drugs act as MAO inhibitors, and using them together can cause a toxic buildup of chemicals in the brain. This can lead to a medical emergency with very high blood pressure.
What to do: Avoid this combination unless it is an emergency and no other options exist. If used together, you must stop tranylcypromine and be monitored very closely by medical staff.
Excessive reduction of blood glucose (additive effect) [See Warnings and Precautions (5.14)] ; CNS depressant agents (including opioids, alcohol, sedatives, hypnotics) Use with caution Increased CNS depression Dietary supplements containing sympathomimetics Contraindicated Antidepressants including but not limited to: • Other MAOIs (e.g., linezolid, intravenous methylene blue, selective MAOIs) • Selective serotonin reuptake inhibitors (SSRIs) and serotonin and norepinephrine reuptake inhibitors (SNRIs) • Tricyclic antidepressants • Amoxapine, bupropion, maprotiline, nefazodone, trazodone, v...
Mechanism: Both drugs increase serotonin levels in the brain, which can lead to a dangerous and life-threatening condition called serotonin syndrome.
What to do: Do not take these medications together. Your doctor will typically require a waiting period of at least 14 days when switching between them.
If in the absence of therapeutic alternatives and emergency treatment with a contraindicated drug (e.g., linezolid, intravenous methylene blue, direct-acting sympathomimetic drugs such as epinephrine) becomes necessary and cannot be delayed, discontinue tranylcypromine tablets as soon as possible before initiating treatment with the other agent, and monitor closely for adverse reactions. Excessive reduction of blood glucose (additive effect) [See Warnings and Precautions (5.14)] ; CNS depressant agents (including opioids, alcohol, sedatives, hypnotics) Use with caution Increased CNS depress...
Mechanism: Tranylcypromine prevents the body from breaking down epinephrine, which can cause a sudden and dangerously high spike in blood pressure.
What to do: Avoid this combination unless it is a medical emergency. If used in an emergency, a doctor must monitor your blood pressure and heart rate very closely.
Excessive reduction of blood glucose (additive effect) [See Warnings and Precautions (5.14)] ; CNS depressant agents (including opioids, alcohol, sedatives, hypnotics) Use with caution Increased CNS depression Dietary supplements containing sympathomimetics Contraindicated Antidepressants including but not limited to: • Other MAOIs (e.g., linezolid, intravenous methylene blue, selective MAOIs) • Selective serotonin reuptake inhibitors (SSRIs) and serotonin and norepinephrine reuptake inhibitors (SNRIs) • Tricyclic antidepressants • Amoxapine, bupropion, maprotiline, nefazodone, trazodone, v...
Mechanism: This combination stops the body from clearing norepinephrine, which can cause blood pressure to rise to levels that may cause a stroke or heart attack.
What to do: Avoid using these drugs at the same time. If they must be used in a hospital setting, your vital signs must be monitored constantly by medical staff.
Common Questions
Can I start tranylcypromine right after stopping another antidepressant?
What foods should I avoid while taking tranylcypromine?
Can I take over-the-counter medicines with tranylcypromine?
What should I do if I experience a severe headache while taking tranylcypromine?
Can tranylcypromine cause problems if I need surgery?
Will this medicine make me gain weight?
Can I drink alcohol while taking tranylcypromine?
What are the signs of a hypertensive crisis?
Is tranylcypromine safe for children and teenagers?
What should I do if I feel my depression is getting worse?
What are the common side effects of tranylcypromine?
Does tranylcypromine interact with other medications?
What drug class is tranylcypromine?
Is tranylcypromine safe during pregnancy?
Is tranylcypromine currently in shortage?
Related Medications in Monoamine Oxidase Inhibitor (MAOI)
Other drugs grouped near tranylcypromine — same-class peers and common alternatives.
acamprosate
Campral
Acamprosate is a medicine that can help you stay away from alcohol if you are alcohol-dependent and have already stopped drinking.
Compare with tranylcypromine →
alprazolam
Xanax
Alprazolam (Xanax) is a medication that can help you with anxiety and panic disorders.
Compare with tranylcypromine →
amitriptyline
Elavil
Amitriptyline is a medicine used to treat depression.
Compare with tranylcypromine →
amphetamine/dextroamphetamine
Adderall, Adderall XR
Adderall XR is a stimulant medicine.
Compare with tranylcypromine →
aripiprazole
Abilify
Aripiprazole (Abilify) is a medicine used to treat certain mental disorders and mood problems.
Compare with tranylcypromine →
Medication Guides
Understanding Drug Interactions
How CYP450 enzymes, inhibitors, and inducers affect your medications
Generic vs Brand Name Drugs
FDA requirements, cost savings, and when the difference matters
Narrow Therapeutic Index Drugs
Why some drugs demand precise dosing and monitoring
Common Drug Interactions
Dangerous medication combinations and how to protect yourself
Related Health & Safety Data
🩺 Find a Doctor
Search prescribers for Monoamine Oxidase Inhibitor (MAOI)
🏨 Hospital Quality
CMS hospital ratings, safety scores & patient outcomes
💊 Supplement Data
NIH DSLD — check supplement ingredients & label claims
🍽️ Food Safety Alerts
FDA recalls, inspections & outbreak investigations
⚠️ Product Recalls
FDA, CPSC & NHTSA recall search
💉 Procedure Costs
Medicare procedure pricing for 9,297 procedures
Save on tranylcypromine
Compare prices and find discounts at pharmacies near you. Free coupons can save up to 80% on prescriptions.
Disclosure: This link may earn us a commission at no extra cost to you. See our terms.
What the FDA Data Shows for tranylcypromine
The FDA label for tranylcypromine (sold under brand names such as Parnate) classifies it as a prescription-only medication in the Monoamine Oxidase Inhibitor (MAOI) class. Tranylcypromine is used to treat major depressive disorder (MDD) in adults. Official labeling lists 9 commonly reported side effects, including Dry mouth, Dizziness, Trouble sleeping.
Post-market surveillance from the FDA Adverse Event Reporting System (FAERS) captures real-world experience. For this drug, FAERS contains 302 voluntary reports. The database also lists 42 documented drug interactions derived from FDA labeling, with the top-flagged interaction rated major severity. NADAC pricing from CMS shows a generic unit cost of $0.70.
Report counts do not establish causation — a FAERS entry documents a temporal association, not proof that the drug produced the outcome. Widely prescribed medications naturally accumulate more reports than niche therapies, so raw totals must be interpreted alongside total exposure. Shortage status, recall history, and patent information further shape supply and switching decisions. This page summarizes public FDA data for educational purposes only and is not a substitute for professional medical advice — always consult a licensed healthcare provider before starting, stopping, or changing any medication.
Data Sources
Drug labeling: FDA Drug Labels (SPL/DailyMed). Adverse events: FDA Adverse Event Reporting System (FAERS). Pricing: CMS National Average Drug Acquisition Cost (NADAC). Shortage status: FDA Drug Shortages Database.
FAERS reports are voluntary and do not establish causation. Drug interactions are derived from FDA labeling and clinical references. Always consult a healthcare professional before making medication decisions.
Last updated: December 20, 2024
Read our methodology — how this data is sourced, computed, and verified.
All federal data sources used on this page
- FDA Orange Book — approved drug products with therapeutic equivalence. accessdata.fda.gov/cder/ob
- FDA DailyMed — NIH-hosted drug labeling for FDA-approved meds. dailymed.nlm.nih.gov
- FDA Adverse Event Reporting System (FAERS) — post-marketing safety surveillance. fda.gov/drugs/faers
- NLM RxNorm — standardized clinical drug nomenclature. nlm.nih.gov/research/umls/rxnorm
- CMS Medicare Part B Drug Average Sales Price Files — federal drug pricing data. cms.gov/medicare/part-b-drugs/asp
- FDA Drug Shortages Database — current and resolved drug shortage tracking. accessdata.fda.gov/drugshortages